Loading data for NVAX — first visit, this takes a few seconds.
Novavax, Inc.
9.26 +0.21 (2.32%)
9.50 +0.85%
- Market Cap
- $1.55B
- Volume
- 4.2M
- Dividend yield
- n/a
- Next earnings date
- Nov 5, 2026
Novavax, Inc. (NVAX) Stock Price, Analysis & Data
Intrinsic Value
Analyst Forecast
Stock Forecasts →Latest Earnings
| Reported | Vs estimate | YoY Change | |
|---|---|---|---|
| Revenue | $56.70M | n/a | -76.30% |
| EPS | -$0,32 | +$0,06 | -151.61% |
Metrics
- Bid
- 6.59
- Market Cap
- 1.55B
- Revenue (ttm)
- 414M
- Net Income (ttm)
- -248M
- 2.45
- -1.53
- n/a
- -15.34
- P/B (ttm)
- -8.14
- P/S (ttm)
- 3.75
- Earnings Date
- Nov 5, 2026
- Ask
- 11
- Volume
- 4,196,996
- Avg. Volume (20D)
- 4,095,785
- Open
- 9.18
- Previous Close
- 9.05
- Day's Range
- 8.89 - 9.34
- 52-Week Range
- 6.20 - 11.97
- Analyst
- n/a
- Price Target
- n/a
- Dividends
- n/a
- Ex-Dividend Date
- n/a
About Novavax, Inc.
View profile →Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Industry Biotechnology
Sector Healthcare
IPO Date Dec 5, 1995
Employees 749
Stock Exchange NasdaqGS
Ticker Symbol NVAX
Website https://www.novavax.com